Compare Medtronic PLC (MDT) vs Tencent Music Entertainment Group - ADR (TME) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Tencent Music Entertainment Group - ADR — how do they compare? Medtronic PLC trades at $89.91 (market cap $116.07B), while Tencent Music Entertainment Group - ADR trades at $8.36 (market cap $16.09B). The key difference: Medtronic PLC is far larger — about 7.2× Tencent Music Entertainment Group - ADR's market cap, and Medtronic PLC pays the higher dividend (3.18%). Which is the better fit depends on your goals.
| MDT | TME | |
|---|---|---|
Market Cap | $116.07B | $16.09B |
Sector | Health | Media |
52-Week High | $105.35 | $26.36 |
52-Week Low | $73.75 | $8.16 |
Enterprise Value | $134.82B | $14.05B |
Dividend Yield | 3.18% | 2.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $89.41, up 2.58% on the day, reflecting positive momentum. The stock exhibits bullish technical signals with strong moving average support and a consensus analyst price target of $98.75. Fundamentally, the company reported revenue of $33.54B for 2025 with a net income margin of 13.2%, and has consistently beaten EPS estimates in recent quarters. Recent news highlights institutional acquisitions and positive developments in medical technology platforms.
The outlook for MDT is positive, driven by earnings beats, robust cash flow, and growth in cardiac and robotic surgery segments. Key opportunities include undervaluation relative to analyst targets and dividend stability. Risks involve rising debt levels and competitive pressures in the medtech sector. The stock presents a compelling case for growth-oriented income investors.
TME stock trades at $9.90, up 3.88% today, with a bullish technical signal from moving averages and oscillators. The company reported Q2 2026 revenue of $8.9 billion (up 6% year-over-year) and net profit of $2.5 billion, beating EPS estimates. Financials show strong profitability with a net income margin of 26.28% and a P/E ratio of 10.29, indicating potential undervaluation. Recent news highlights mixed quarterly performance with revenue growth slowing but profit beating expectations.
The outlook for TME is cautiously optimistic, supported by solid fundamentals and bullish analyst sentiment, but risks include intensifying competition, user churn, and AI-related copyright issues. Upside potential exists from premium membership growth and ecosystem integration, though near-term volatility may persist due to market conditions and operational challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Tencent Music Entertainment Group - ADR
TME is the largest online music service provider in China. It was founded in 2016 with the business combination of QQ Music (founded in 2005), Kuwo Music (founded in 2005) and Kugou Music (founded in 2004) streaming platforms. Tencent is the largest shareholder of TME with over 50% shares and over 90% voting rights held. TME also provides social entertainment services, including music live audio/video broadcasts and online concert services through the three platforms mentioned above, and online karaoke through an independent platform WeSing.
Read more on TME →
